Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation (Q33703397)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

4

object named as

Richard Bucala

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Katherine L Meyer-Siegler

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jacob Cox

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lin Leng

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Pedro L Vera

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

16 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

290

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

49-57

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Many cytokines are very useful therapeutic targets in disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Role of MIF in inflammation and tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Regulatory pathways in inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Differential regulation and properties of MAPKs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

A statistical model for identifying proteins by tandem mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

Determination of antithrombin activity by an amidolytic and a clotting procedure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

21 June 2018

A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

30 October 2018

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

30 October 2018

Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832085

30 October 2018

Protection from septic shock by neutralization of macrophage migration inhibitory factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraluminal antibodies to macrophage migration inhibitory factor decrease substance P induced inflammatory changes in the rat bladder and prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III and Factor VIII in Patients with Neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the antithrombin III heparin binding site

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombin induced secretion of macrophage migration inhibitory factor (MIF) and its effect on nuclear signaling in endothelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/19762145

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CANLET.2009.08.025

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33703397&oldid=1958095969"